BioCentury
ARTICLE | Clinical News

Pagoclone: Began Phase II trial

January 22, 2001 8:00 AM UTC

Interneuron Pharmaceuticals Inc. (IPIC), Lexington, Mass. Product: Pagoclone Business: Neurological Therapeutic category: Neurotransmission Target: GABA receptors Description: Cyclopyrrolone that mod...